Zelluna ASA 2025 SR
The report outlines Zelluna's environmental, social, and governance performance for the fiscal year 2025, highlighting its transition from a preclinical to a clinical-stage biotechnology company. Key achievements include reporting zero whistleblower incidents and zero quality or safety incidents leading to regulatory actions. On the environmental front, the company measured its Scope 1 emissions at 0 tonnes CO2e and Scope 2 emissions at 1.45 tonnes CO2e, with approximately 80% of its indirect energy use sourced from hydropower. Additionally, Zelluna conducted human rights due diligence assessments in compliance with the Norwegian Transparency Act, identifying no actual adverse impacts or material risks in its operations or supplier network.
Company: Zelluna ASA
Sector: Health Care
Country: Norway
Year: 2025
Type: SR
Pages: 12
Zelluna ASA
ESG Report
The report outlines Zelluna's environmental, social, and governance performance for the fiscal year 2025, highlighting its transition from a preclinical to a clinical-stage biotechnology company. Key achievements include reporting zero whistleblower incidents and zero quality or safety incidents leading to regulatory actions. On the environmental front, the company measured its Scope 1 emissions at 0 tonnes CO2e and Scope 2 emissions at 1.45 tonnes CO2e, with approximately 80% of its indirect energy use sourced from hydropower. Additionally, Zelluna conducted human rights due diligence assessments in compliance with the Norwegian Transparency Act, identifying no actual adverse impacts or material risks in its operations or supplier network.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2025
Reporting Period
Jan 1, 2025 - Dec 31, 2025
Fiscal Year
2025
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Water Consumption
Total Waste
Women on Board
Employees